Other
Software amortization expense
Vertex Pharmaceuticals Software amortization expense remained flat by 0.0% to $7.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $6.30M to $7.80M. Over 2 years (FY 2023 to FY 2025), Software amortization expense shows an upward trend with a 62.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
An increase reflects higher historical investment in technology, while a decrease may suggest a slowdown in digital infrastructure spending.
Detailed definition
This represents the periodic expense recognized as capitalized software costs are systematically written off over their...
Peer comparison
Standard accounting practice for companies with significant technology assets.
Metric ID:
other_capitalized_computer_software_amortization1Historical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $11.80M | $25.20M | $31.20M |
| YoY Change | — | +113.6% | +23.8% |
Range$11.80M – $31.20M
CAGR+62.6%
Avg YoY Growth+68.7%
Median YoY Growth+68.7%
Current Streak2+ years growth
Software amortization expense at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's software amortization expense?
- Vertex Pharmaceuticals (VRTX) reported software amortization expense of $7.80M in Q4 2025.
- How has Vertex Pharmaceuticals's software amortization expense changed year-over-year?
- Vertex Pharmaceuticals's software amortization expense increased by 23.8% year-over-year, from $6.30M to $7.80M.
- What is the long-term trend for Vertex Pharmaceuticals's software amortization expense?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's software amortization expense has grown at a 62.6% compound annual growth rate (CAGR), from $11.80M to $31.20M.
- What does software amortization expense mean?
- The annual expense recognized from the cost of previously purchased or developed software.